title: Predictors of outcome in patients with normal-pressure hydrocephalus.
abstract: Despite knowledge emerging over the last 40 years, the postoperative results after shunt implantation in patients diagnosed with normal-pressure hydrocephalus (NPH) have not improved significantly over the last decade. For that reason predictors have to be identified in order to preoperatively predict outcome. From 1982 to 2000 we prospectively studied 200 patients diagnosed with NPH. From the patients, who were surgically treated by a shunt implantation we reexamined 155 (78%) postoperatively a mean time interval of 7 months. The NPH was graded according to the results of the intrathecal infusion test in an early stage NPH (without brain atrophy) and late stage NPH (with brain atrophy). In our study, we focussed attention on the possible predictors: patients age, length of disease, clinical signs (gait ataxia, dementia and bladder incontinence), aetiology idiopathic/secondary as well as implanted valve type and the value of resistance to cerebrospinal fluid outflow. To measure the outcome we used the NPH recovery rate and as the statistical test the chi(2) according to Pearson. In 80 patients with an early stage NPH (without cerebral atrophy), a short course of disease (<1 year), a slight degree of dementia and an implanted Miethke-Dual-Switch valve were significant predictors for a positive postoperative outcome. The outflow resistance measured in the intrathecal infusion test showed only a minimal relevance to outcome. Those 75 patients with a late state NPH (with cerebral atrophy) had a better outcome when dementia was not present, the outflow resistance was above 20mm Hg/min/ml, the CSF tap-test was positive and a Miethke-Dual-Switch valve was implanted.
authors.affiliation: Department of Neurosurgery, Unfallkrankenhaus Berlin, Germany. ullrich.meier@ukb.de
authors.forename: Ullrich
authors.initials: U
authors.lastname: Meier
authors.forename: Christoph
authors.initials: C
authors.lastname: Miethke
mesh_terms: D001284:Atrophy; D001921:Brain / Q000473:pathology; D002557:Cerebrospinal Fluid Shunts / Q000009:adverse effects*; D004244:Dizziness / Q000453:epidemiology; D005242:Fecal Incontinence / Q000453:epidemiology; D020234:Gait Ataxia / Q000453:epidemiology; D006801:Humans; D006850:Hydrocephalus, Normal Pressure / Q000523:psychology / Q000601:surgery*; D009043:Motor Activity; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012189:Retrospective Studies; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000453:epidemiology